Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: High incidence of interstitial lung disease following practical use of osimertinib in patients who had undergone immediate prior nivolumab therapy, Annals of Oncology, March 2017, Elsevier,
DOI: 10.1093/annonc/mdw647.
You can read the full text:
Contributors
The following have contributed to this page